A new study found that at least 70 genetic mutations are involved in the formation of colon cancer, significantly more than was previously thought, according to a news release by UT Southwestern ...
One in 6 patients with colorectal cancer have an inherited cancer-related gene mutation which likely predisposed them to the disease, according to a Mayo Clinic study. About 16 percent of the 361 ...
For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.
Researchers show that genetic analysis of colorectal polyps can uncover cancer predisposition missed by blood-based testing.
Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval. According to the National Cancer ...
Taking aspirin on a daily basis protects against the recurrence of colon cancer, a new study found. People who took aspirin every day for three years had a 55% reduced risk of colorectal cancer tumors ...
Researchers from Japan report that they have characterized gene mutations in colorectal cancer (CRC) tumors with high tumor mutation burden that lack mutations in the major oncogenes. Their findings ...
In a new study, low-dose daily aspirin roughly halved the risk of cancer coming back for patients whose tumors had a specific genetic mutation. Daily low-dose aspirin halves the risk of colorectal ...
As a mother, hearing about rising cancer rates in young people is deeply concerning, but new research offers crucial insight into why colorectal cancer is increasingly affecting younger generations.
A new clinical trial tested low-dose aspirin in patients with colon and rectal cancer, also referred to as colorectal cancer. The researchers wanted to see if taking aspirin daily could help prevent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results